MRK Competitors & Alternatives
Compare Merck & Company Inc with similar stocks in the same industry
Drug Manufacturers - General
MRK
Main Stock$118.27
Tradestie Score
59
Market Cap
$225.13B
P/E Ratio
32.1
Revenue Growth
0.0%
Analyst Upside
+9.7%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABBV
ABBVIE INC.
|
$233.36
|
$431.71B | 106.1 | 58 | Compare |
|
PG
Procter & Gamble Company
|
$150.87
|
$358.52B | 22.0 | 62 | Compare |
|
NVO
Novo-Nordisk A/S
|
$47.06
|
$262.92B | 10.1 | 57 | Compare |
|
AZN
AstraZeneca PLC
|
$180.21
|
$261.56B | 26.3 | 52 | Compare |
|
NVS
Novartis AG
|
$151.60
|
$254.99B | 21.0 | 56 | Compare |
|
VZ
Verizon Communications
|
$45.98
|
$184.80B | 11.1 | 56 | Compare |
|
AMGN
Amgen Inc
|
$349.14
|
$160.70B | 23.5 | 59 | Compare |
|
PFE
Pfizer Inc.
|
$24.87
|
$154.70B | 19.2 | 53 | Compare |
|
GILD
Gilead Sciences Inc
|
$126.48
|
$137.92B | 16.8 | 58 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$42.02
|
$121.27B | 18.4 | 43 | Compare |
More MRK Analysis
Data updated: Jun 23, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry